Before considering studies on specific therapeutic approaches, we begin with a review of the neurologic disorders caused by progranulin insufficiency and other diseases associated with progranulin, key features of progranulin biology, and the currently available mouse models and outcome measures used in preclinical studies on progranulin therapeutics. This evidence concerns the gene GRN and nervous system disorder.